Skip to main content
OSTEONIC Co., Ltd. logo

OSTEONIC Co., Ltd. — Investor Relations & Filings

Ticker · 226400 ISIN · KR7226400000 KO Manufacturing
Filings indexed 292 across all filing types
Latest filing 2025-03-10 AGM Information
Country KR South Korea
Listing KO 226400

About OSTEONIC Co., Ltd.

http://osteonic.com/eng/

OSTEONIC Co., Ltd. is a medical device company specializing in the development and manufacturing of bone fixation and reconstructive implants. The company produces a comprehensive portfolio of products using both metallic and biodegradable composite materials. Its key product lines provide solutions for osteosynthesis and internal fixation in various surgical fields, including Cranio-Maxillofacial (CMF), trauma, sports medicine, spine, and neurosurgery. OSTEONIC operates its own mass production facilities and distributes its products to physicians and hospitals through a global sales network.

Recent filings

Filing Released Lang Actions
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted by Osteonic regarding the scheduling of their Annual General Meeting (AGM) on a 'concentrated date' (a date when many companies hold their AGMs). It explains the reasons for choosing this date and acknowledges the regulatory context of shareholder meeting dispersion. Since it is a regulatory notification regarding the meeting logistics rather than the meeting materials themselves or the results, it falls under the general regulatory filing category.
2025-03-10 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Osteonic Co., Ltd. It includes the meeting agenda, date, location, and detailed business reports (management discussion, financial statements, and governance information) to be presented to shareholders. This type of document is a standard proxy statement/information circular provided to shareholders ahead of an Annual General Meeting (AGM). In the context of the provided categories, this fits the 'Proxy Solicitation & Information Statement' (PSI) classification, as it serves to inform shareholders and solicit their participation/votes for the upcoming meeting.
2025-03-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (stock-backed loans) of major shareholders and special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-03-07 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership by Fine Value Asset Management in the company Osteonic. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-02-27 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Osteonic) announcing a significant change (over 15-30%) in revenue or profit structure. This is a standard 'Earnings Release' (ER) filing in the Korean market, providing preliminary financial highlights before the final audited annual report is published. It contains key financial metrics like revenue, operating profit, and net income, and explicitly states it is based on internal data prior to final audit completion. FY 2024
2025-02-11 Korean
교환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is an official regulatory filing from the Korean Exchange (KRX) regarding the exercise of exchange rights (교환청구권행사) for exchangeable bonds. It details the number of shares issued, the impact on total shares, and the remaining balance of the exchangeable bonds. This falls under capital structure changes and financing updates, specifically related to the conversion of debt into equity, which is best categorized as a Capital/Financing Update (CAP).
2025-02-10 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.